RECIL Versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-To-Head Comparison in 54 Patients
Cancers - Switzerland
doi 10.3390/cancers12010009
Full Text
Open PDFAbstract
Available in full text
Date
December 18, 2019
Authors
Publisher
MDPI AG